Tonkin A M, Lester R M, Guthrow C E, Roe C R, Hackel D B, Wagner G S
Circulation. 1975 Apr;51(4):627. doi: 10.1161/01.cir.51.4.627.
The specificity of serum CPK-MB for acute myocardial infarction was examined by retrospective analysis of 401 consecutive patients admitted to Coronary Care Unit over a three and one-half year period with suspected infarction in whom the isoenzyme was subsequently detected. Four patients (1 per cent) who died during the hospital admission had no autopsy evidence of acute myocardial infarction. All four had experienced mild iatrogenic cardiac trauma, following which serum CPK-MG persisted for at least 24 hours. In one patient, a permanent pacemaker had been inserted by the transmediastinal approach. Two patients had been subjected to closed chest cardiac massage and intracardiac puncture, and one to external cardiac massage alone. The findings suggest that persistent identification of serum CPK-MB, although specific for myocardial necrosis, cannot be regarded as diagnostic of myocardial infarction. The implications of this are important to treatment of patients after cardiopulmonary resuscitation and operative trauma to the heart.
通过对连续三年半期间入住冠心病监护病房且疑似心肌梗死的401例患者进行回顾性分析,检测血清肌酸磷酸激酶同工酶MB(CPK-MB)对急性心肌梗死的特异性,这些患者随后均检测到了该同工酶。4例(1%)住院期间死亡的患者并无急性心肌梗死的尸检证据。这4例患者均经历了轻度医源性心脏创伤,之后血清CPK-MG持续至少24小时。其中1例患者经纵隔途径植入了永久性起搏器。2例患者接受了胸外心脏按压和心内穿刺,1例仅接受了胸外心脏按压。这些发现表明,血清CPK-MB虽对心肌坏死具有特异性,但持续检测到该指标不能被视为心肌梗死的诊断依据。这对于心肺复苏后及心脏手术创伤患者的治疗具有重要意义。